Guest guest Posted June 20, 2006 Report Share Posted June 20, 2006 Fibromyalgia & Fatigue Centers, Inc. Announces Teitelbaum, MD as New Medical Director Dallas, TX, June 19, 2006—Fibromyalgia & Fatigue Centers, Inc. (FFC) has announced the appointment of Teitelbaum, MD, as their new Medical Director. A leader in effective therapies for Fibromyalgia and Chronic Fatigue Syndrome for the last 25 years, Dr. Teitelbaum will head up medical education programs for the company's clinics as well as outreach to the public and media. Currently FFC operates 15 clinics in 12 states with plans for expansion into other regions of the U.S. Dr. Teitelbaum is author of the perennial best-seller From Fatigued to Fantastic! (Avery Penguin Putnam) and the recently published Pain Free 1-2-3: A Proven Program for Eliminating Chronic Pain Now (McGraw-Hill, 2006). He is senior author of the landmark studies " Effective Treatment of Chronic Fatigue Syndrome and Fibromyalgia—A Placebo-Controlled Study " (Journal of Chronic Fatigue Syndrome, 8:2, 2001), and " Effective Treatment of CFS and Fibromyalgia with D-Ribose. " Dr. Kent Holtorf, who served as FFC's Medical Director since the company's inception 2 ½ years ago, will assume a new role as Chief of the Medical Advisory Board starting July 1, 2006. " We are delighted to have Dr. Teitelbaum as our new Medical Director, " said S. Baurys II, FFC's Founder and Chairman of the Board. " His expertise in treating Fibromyalgia (FMS) and Chronic Fatigue Syndrome (CFS) for over 25 years reinforces our position as the leading diagnostic and treatment center for these conditions in the world. " He added that Dr. Holtorf and Dr. Teitelbaum are in agreement on foundations for the standard of care for FMS and CFS and are committed to working together to ensure a smooth transition for FFC. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.